comparemela.com

Latest Breaking News On - Stelios papadopoulos - Page 1 : comparemela.com

The latest drinks to add to your listings - hospitality

The latest drinks to add to your listings - hospitality
hospitalitymagazine.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hospitalitymagazine.com.au Daily Mail and Mail on Sunday newspapers.

New south walesChristina trabuccoStelios papadopoulosReef restoration foundationIcebergs dining roomFounder christinaOcean grown

Biogen shareholders vote in favor of new board member

BioPharma

Alexander dennerStelios papadopoulosSusan langerBob langerChristopher viehbacherRichardc mulliganWilliam jonesBrian abrahamsMassachusetts institute of technologyExchange commissionParatus sciencesSouffle therapeuticsKojin therapeuticsGold silverMassachusetts institute

Biogen : Announces 2023 Annual Shareholder Meeting Preliminary Results

Cambridge, Mass. - June 26, 2023 - Biogen Inc. (Nasdaq: BIIB) today held its Annual Meeting of shareholders. As previously announced, Caroline Dorsa has succeeded Stelios Papadopoulos as Chair of the Board of Directors at conclusion of the.

United kingdomRichardc mulliganWilliamd jonesStelios papadopoulosSusan langerAlexanderj dennerBiogen incExchange commissionAnnual meetingCaroline dorsaBoard chair stelios papadopoulosBiogen boardCurrent report

Regulus Therapeutics Announces Appointment of Preston S Klassen, M D to its Board of Directors

/PRNewswire/ Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines.

United statesSan diegoStelios papadopoulosPrestons klassenPreston klassenHead of researchPrnewswire regulus therapeutics incRnas the company or regulusArena pharmaceuticalsCompany board of directorsUniversity of nebraska medical centerHead of global development at orexigen therapeuticsRegulus therapeutics incHead of research developmentRegulus therapeuticsExecutive vice president

Royal Bank of Canada Trims North West (OTCMKTS:NNWWF) Target Price to C$36 00

Exelixis, Inc. (NASDAQ:EXEL – Get Rating) has been assigned an average rating of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 month price objective among brokerages […]

Jeffrey hessekielStifel nicolausSecurities exchange commissionBlackrock incExelixis company profileVanguard group incMorgan stanleyExelixis incRenaissance technologiesWells fargo companyFarallon capital managementEf hutton acquisition coGet ratingTrading downExchange commissionCapital management

vimarsana © 2020. All Rights Reserved.